Managing alcoholic liver disease
Clinical and Molecular Hepatology
; : 212-219, 2015.
Article
in En
| WPRIM
| ID: wpr-157208
Responsible library:
WPRO
ABSTRACT
Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management of this condition, although specific roles for liver biopsy still remain particularly in the setting of alcoholic hepatitis. Despite a large number of recent treatment trials, the ideal pharmacotherapy approach remains undefined. Most essential is the supportive care and focus on abstinence and nutrition. Owing in part to a great deal of attention from governmental funding sources, a number of new treatment approaches are undergoing rigorous evaluation, hopefully providing future treatment options in this very severe condition.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Pentoxifylline
/
Prognosis
/
Biomarkers
/
Interleukins
/
Liver Transplantation
/
Adrenal Cortex Hormones
/
Liver Diseases, Alcoholic
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Clinical and Molecular Hepatology
Year:
2015
Type:
Article